H.I.G. BioHealth Partners

H.I.G. BioHealth Partners, now operating as H.I.G. HealthBridge, serves as the dedicated life sciences investment affiliate of H.I.G. Capital. The firm invests across a broad spectrum of biohealth opportunities, including pharmaceuticals, medical devices, diagnostics, and digital health. Its core offering provides strategic capital and operational guidance, accelerating the development of growth-stage companies.

Founded in 2011, the firm emerged as H.I.G. Capital's specialized platform to address the growing capital needs and opportunities within the biohealth sector. The core insight involved leveraging the parent company's extensive investment expertise for targeted life science support. This established a dedicated vehicle for nuanced healthcare innovation, distinct from broader investment strategies.

The firm supports growth-stage biohealth companies, offering financial backing and operational partnership to scale their solutions. H.I.G. BioHealth Partners aims to drive advancements that improve patient outcomes and create more efficient healthcare systems. Its vision centers on fostering innovation across the biohealth continuum, actively shaping the future of global health solutions.